| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.4 | 2e-30 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-15 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-14 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.3 | 4e-09 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-09 |